T1	p 70 74	cows
T2	p 85 116	against Clostridium difficile .
T3	p 170 174	cows
T4	p 208 219	Clostridium
T5	p 354 370	patients with C.
T6	p 630 648	non-immunized cows
T7	p 797 813	77 patients with
T8	p 1091 1099	patients
T9	p 1105 1109	CDAD
T10	p 1207 1218	individuals
T11	p 1224 1228	CDAD
T12	i 20 57	whey protein concentrate derived from
T13	i 119 157	whey protein concentrate prepared from
T14	i 264 269	toxin
T15	i 272 281	and toxin
T16	i 464 522	anti-C. difficile whey protein concentrate ( anti-CD WPC )
T17	i 584 592	raw milk
T18	i 674 685	anti-CD WPC
T19	i 701 735	regular whey protein concentrate .
T20	i 848 869	consuming anti-CD WPC
T21	i 1057 1068	anti-CD WPC
T22	i 1176 1187	anti-CD WPC
T23	o 93 104	Clostridium
T24	o 208 219	Clostridium
T25	o 392 400	diarrhea
T26	o 438 449	infection .
T27	o 454 460	safety
T28	o 584 592	raw milk
T29	o 659 670	composition
T30	o 734 735	.
T31	o 936 960	adverse event monitoring
T32	o 1001 1014	hematological
T33	o 1019 1042	biochemical assessments